Neumora Therapeutics (NMRA) Share-based Compensation (2022 - 2026)
Neumora Therapeutics' Share-based Compensation was $7.18 million in Q2 2026, up 0.3% from $7.17 million a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Share-based Compensation (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neumora Therapeutics' Share-based Compensation was $27.98 million through Jun 30, 2026, down 23.0% year-over-year; for FY2025, it came in at $29.88 million, down 25.3% from FY2024.
- Share-based Compensation shows a three-year compound annual growth rate of 53.3% (FY2022 to FY2025).
- In earlier years, Share-based Compensation was $39.99 million in FY2024 (+132.0%), $17.24 million in FY2023 (+107.8%) and $8.3 million in FY2022.
- Quarterly Share-based Compensation has moved between $2.2 million (Q1 2023) and $12.77 million (Q2 2024) over five years.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 1.9%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2024 (growth of 402.1%); the worst was Q2 2025 (a decline of 43.9%).
- Per Business Quant data, NMRA's Share-based Compensation in the three quarters before Q2 2026 was $7.41 million (Q1 2026), $7.41 million (Q4 2025) and $5.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Neumora Therapeutics | 129.65 Mn | 129.65 Mn | - | 7.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.18 Mn |
| Mar 31, 2026 | 7.41 Mn |
| Dec 31, 2025 | 7.41 Mn |
| Sep 30, 2025 | 5.98 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 9.32 Mn |
| Dec 31, 2024 | 9.90 Mn |
| Sep 30, 2024 | 9.95 Mn |
| Jun 30, 2024 | 12.77 Mn |
| Mar 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 2.79 Mn |
API Access
Neumora Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();